Local drug delivery for the prevention of restenosis. Fact, fancy, and future.
about
Heparin and coumadin versus acetylsalicylic acid for prevention of restenosis after coronary angioplastyPhotodynamic therapy with local photosensitizer delivery inhibits experimental intimal hyperplasia.Restenosis following coronary angioplasty: current statusNanotechnology approaches to improve dental implantsNew catheter-based technology for the treatment of restenosis.Targeting the cell cycle machinery for the treatment of cardiovascular disease.In stent restenosis: bane of the stent era.Perspectives on the role of nanotechnology in bone tissue engineering.Anti-inflammatory effect of abciximab-coated stent in a porcine coronary restenosis modelPaclitaxel-eluting balloon: from bench to bed.Peripheral applications of drug-coated balloons: past, present and future.Amphotropic but not atherotropic: another caveat for adenoviral gene therapy.The arterial wall: a new pharmacological and therapeutic target.The unusual routes of administration.Prevention of restenosis: is angioplasty the answer?Local intramural delivery of 60% ethyl alcohol for treatment of recalcitrant in-stent restenosis.Effect of percutaneous adenovirus-mediated Gax gene delivery to the arterial wall in double-injured atheromatous stented rabbit iliac arteries.Production and in vitro characterization of lisinopril-loaded nanoparticles for the treatment of restenosis in stented coronary arteries.Survival of endothelial cells in vitro on Paclitaxel-loaded coronary stents.Effect of a novel drug-eluted balloon coated with genistein before stent implantation in porcine coronary arteries.Endoluminal local delivery of PCNA/cdc2 antisense oligonucleotides by porous balloon catheter does not affect neointima formation or vessel size in the pig coronary artery model of postangioplasty restenosis.Effect of blood flow on near-the-wall mass transport of drugs and other bioactive agents: a simple formula to estimate boundary layer concentrations.Quantitative evaluation of local drug delivery using the InfusaSleeve catheter.Targeted Treatments for Restenosis and Vein Graft Disease
P2860
Q28192448-B5400FC2-1CB1-40A6-8C41-E8D8AE3B92D3Q31934463-ECD58994-5ED8-49B3-A7E2-6E8649983A45Q34395052-094B9D7C-23AC-4F53-B8AA-DD7A697E4F48Q34929711-A4E8C394-090F-45EF-A3CB-D94A163F1AA1Q35002613-0076FCE5-2262-4CBC-A3A1-0410F1F3AC83Q35164884-A83DE2FD-F5E1-4154-B6A9-0F1C665936F4Q35769824-F0C81961-F05C-4A41-AC04-274C26759173Q36802478-BCB33F36-50E4-434F-9689-001EE5BB427FQ37221177-EAAF803F-A189-4085-B61D-70DF0C0EE612Q37421881-2441F71B-B5D3-44FF-B174-47BC69F7A4D7Q38036967-4A934D13-E22D-49D5-9E12-2C82D563C83DQ40343829-A21625CA-9C26-4F9D-997C-A8507675269EQ41135818-29A73191-1B1A-4EC9-A816-2A2F1C20420AQ41138086-489F3EF3-21C0-483D-A9B9-4B20DB251CBDQ42409598-DEF03E0E-8451-406B-9361-875C09A9800EQ44779709-881B83EA-DBE5-4BD1-BC88-7AD59DA1A8C9Q45870659-17F8DDAE-EF04-4DEB-BBD6-AAED30DC7242Q46111538-6C36F175-53D5-4E01-99BC-0890E35CCECEQ46191693-AB2320C5-9FA9-4F51-960F-ABD797976EA7Q46382614-29BD823D-91B8-4164-8C34-F44B3E865EFBQ47306378-3C958F68-C418-4965-AB37-66FBBED6BADEQ47773008-C3EDA0B9-2FC9-4832-B666-A417D48482A2Q49108524-E47C238B-CAE5-4718-8CEE-F9EDC4413266Q58691736-7A43E509-0182-4B28-BF52-929C207334F9
P2860
Local drug delivery for the prevention of restenosis. Fact, fancy, and future.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Local drug delivery for the prevention of restenosis. Fact, fancy, and future.
@en
type
label
Local drug delivery for the prevention of restenosis. Fact, fancy, and future.
@en
prefLabel
Local drug delivery for the prevention of restenosis. Fact, fancy, and future.
@en
P356
P1433
P1476
Local drug delivery for the prevention of restenosis. Fact, fancy, and future.
@en
P2093
Lincoff AM
P304
P356
10.1161/01.CIR.90.4.2070
P407
P577
1994-10-01T00:00:00Z